The use of inferior vena cava filters in the US dropped from 55.1 per 100,000 people in 2010 to 39.1 per 100,000 in 2014 due to a safety alert issued by the FDA in 2010 that was prompted by more than 900 reports of device-related adverse events, according to a study in JAMA Internal Medicine. The findings, based on National Inpatient Sample data for over 1 million patients who underwent IVC filter placement from 2005 to 2014, showed that despite the downturn, the 2014 rate remained 10 times higher than the rate in Europe.
Study shows steady drop in US inferior vena cava filter usage
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.